- Home
- HOVR vs CRVO Comparison
HOVR vs CRVO Comparison
Compare HOVR & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOVR
- CRVO
- Stock Information
- Founded
- HOVR 2013
- CRVO 2001
- Country
- HOVR Canada
- CRVO United States
- Employees
- HOVR N/A
- CRVO N/A
- Industry
- HOVR Blank Checks
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- HOVR Finance
- CRVO Health Care
- Exchange
- HOVR Nasdaq
- CRVO Nasdaq
- Market Cap
- HOVR 62.1M
- CRVO 67.4M
- IPO Year
- HOVR N/A
- CRVO N/A
- Fundamental
- Price
- HOVR $1.61
- CRVO $10.21
- Analyst Decision
- HOVR Strong Buy
- CRVO Strong Buy
- Analyst Count
- HOVR 1
- CRVO 6
- Target Price
- HOVR $2.00
- CRVO $20.80
- AVG Volume (30 Days)
- HOVR 651.0K
- CRVO 120.7K
- Earning Date
- HOVR 10-09-2025
- CRVO 08-08-2025
- Dividend Yield
- HOVR N/A
- CRVO N/A
- EPS Growth
- HOVR N/A
- CRVO N/A
- EPS
- HOVR 0.12
- CRVO N/A
- Revenue
- HOVR N/A
- CRVO $7,776,968.00
- Revenue This Year
- HOVR N/A
- CRVO N/A
- Revenue Next Year
- HOVR N/A
- CRVO N/A
- P/E Ratio
- HOVR $12.95
- CRVO N/A
- Revenue Growth
- HOVR N/A
- CRVO N/A
- 52 Week Low
- HOVR $0.24
- CRVO $1.80
- 52 Week High
- HOVR $2.52
- CRVO $20.63
- Technical
- Relative Strength Index (RSI)
- HOVR 46.91
- CRVO 60.35
- Support Level
- HOVR $1.65
- CRVO $9.26
- Resistance Level
- HOVR $1.90
- CRVO $10.89
- Average True Range (ATR)
- HOVR 0.13
- CRVO 0.64
- MACD
- HOVR -0.01
- CRVO 0.03
- Stochastic Oscillator
- HOVR 34.09
- CRVO 58.23
About HOVR New Horizon Aircraft Ltd.
New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and aiming to build a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, Floods and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.